Filter posts

The Investment Landscape in Brazil

Brazil has been at the forefront of biotech news recently, with China announcing plans to …

FOIA Attacks Against Biotech Scientists Get Personal

Much has been written and discussed online about the relationships between independent researchers and industry …

Reality Check for AHIP: Competition Driving Down Costs for Hepatitis C Meds

Yesterday¬†at a House Judiciary Committee hearing on competition in the healthcare marketplace, AHIP Executive Vice …

Here are the Facts about the IPR Kill Rate

FiercePhrma recently ran an article repeating a dubious analysis of the crisis caused by the …

BIO Statement: Institute for Clinical and Economic Review Framework

This week, the Institute for Clinical and Economic Review (ICER) released its Value Assessment Framework. …

Health Affairs Study: Want to save money in Medicaid? Increase adherence.

At BIO, we have long argued that the use of prescription medicines can yield substantial …